NYSE:HIMS
Hims & Hers Health, Inc.
Hims & Hers Health, Inc.'s revenue grew 59.0% in fiscal 2025 to $2.3B while operating margin rose to 4.5%, its highest in 7 years. Free cash flow was $57.4M, 2.4% of revenue, and the diluted share count rose 9.0%.Summary generated from Hims & Hers Health, Inc.'s SEC filings. Latest annual report filed Feb 23, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.3B
Revenue growth+59.0%
Revenue, 5-yr CAGR+73.6%
Gross margin73.8%
Operating margin4.5%
Net margin5.5%
ROICn/a
Return on equity25.2%
Debt / equityn/a
Free cash flow$57.4M
FCF margin2.4%
Share count change+9.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 272 | 527 | 872 | 1,477 | 2,348 |
| Operating income | −115 | −69 | −29 | 62 | 106 |
| Net income | −108 | −66 | −24 | 126 | 128 |
| Free cash flow | n/a | −34 | 47 | 198 | 57 |
Recent filings
- 8-KDirector or officer change
Oct 7, 2026 - 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 8-KDirector or officer change
Jul 17, 2026 - 8-KEntry into a material agreement
Jul 1, 2026 - 8-KResults of a shareholder vote
Jun 15, 2026